There is the registration on new IP coming out of the phase 2 in oral Nadolol.
Glass will be presenting results as soon as the further results are in and there will be academic interest.
Zafirlukast could hit a development milestone with toxicity testing as could inhaled Nadolol .
Partnering is of course the only way forward for any of these projects . The company is almost out of funds .
Anybody else?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
0.003(3.19%) |
Mkt cap ! $8.232M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $3.425K | 34.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5200 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 244080 | 3 |
View Market Depth
| Last trade - 15.55pm 25/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |